A comprehensive review of canine hypothyroidism: Clinical features, laboratory diagnosis, and therapeutic approaches

Introduction 1.1 Definition

Hypothyroidism in dogs is a clinical condition characterized by a deficiency of thyroid hormones, primarily thyroxine (T 4 ) and triiodothyronine (T 3 ), produced by the thyroid gland. This hormonal insufficiency leads to a reduction in the basal metabolic rate, which manifests as multisystemic clinical signs affecting dermatologic, neurologic, reproductive, and metabolic functions (Mooney, 2011) [16] .

Epidemiology and Prevalence

Canine hypothyroidism is considered the most common endocrine disorder in middle-aged dogs, particularly in breeds such as Golden Retrievers, Doberman Pinschers, Irish Setters, and Dachshunds (Ferguson, 1994) [6] . The estimated prevalence is 0.2-0.8% of the general canine population, although underdiagnosis is common due to the vague and non-specific nature of the clinical signs (Peterson et al., 1997) [20] . Females and males are equally affected, with onset typically between 4 to 10 years of age (Graham, 2007) [7] .

Importance of Thyroid Hormones

Thyroid hormones play a pivotal role in regulating carbohydrate, protein, and lipid metabolism, maintaining thermoregulation, influencing erythropoiesis, and modulating cardiovascular function (Dixon, 2005) [3] . Deficiency of these hormones disrupts homeostasis and results in gradual clinical deterioration.

Historical Perspective

Hypothyroidism in dogs was first clinically recognized in the early 20th century, but its detailed pathophysiology and diagnostic criteria have only been refined in the last 50 years with the advent of radioimmunoassay and more sensitive thyroid function tests (Kemppainen, 1994) [9] .

Clinical Relevance

The clinical significance of hypothyroidism lies in its insidious presentation. Dogs may initially present with vague signs such as lethargy, weight gain, or poor coat condition. Without diagnosis and management, progressive metabolic imbalance and secondary complications-such as neuropathies, infertility, and dermatological disorders-can develop (Scott-Moncrieff, 2015) [21] . Early recognition is therefore critical for improving prognosis.

Etiology and Pathogenesis

Hypothyroidism in dogs is primarily a disorder of the thyroid gland (primary hypothyroidism), but can also result from pituitary or hypothalamic dysfunction (secondary or tertiary hypothyroidism). The pathogenesis involves progressive destruction of thyroid tissue, impaired hormone synthesis, or disruption of the hypothalamic-pituitary-thyroid (HPT) axis.

Classification of Hypothyroidism 2.1.1 Primary Hypothyroidism 2.1.1.1 Lymphocytic Thyroiditis

An immune-mediated process accounts for nearly 50% of primary cases (Graham, 2007) [7] . Histologically, thyroid follicles are infiltrated by lymphocytes, plasma cells, and macrophages, leading to glandular atrophy. Autoantibodies against thyroglobulin and thyroid peroxidase are often detectable (Graham et al., 2002) [8] .

Idiopathic Follicular Atrophy

In this form, the thyroid parenchyma is progressively replaced by adipose tissue without an obvious inflammatory component. The pathogenesis is not fully understood, but it is considered either a primary degenerative process or the end stage of autoimmune thyroiditis (Peterson et al., 1997) [20] . Together, lymphocytic thyroiditis and idiopathic atrophy account for > 95% of cases of hypothyroidism in dogs (Feldman & Nelson, 2004) [5] .

Secondary Hypothyroidism

This is rare (<5% of cases) and occurs due to deficiency of pituitary TSH secretion, often caused by pituitary tumors, congenital hypoplasia, or trauma (Dixon, 2005) [3] .

Tertiary Hypothyroidism

Extremely uncommon, resulting from hypothalamic failure to secrete thyrotropin-releasing hormone (TRH).

Iatrogenic Hypothyroidism

May follow thyroidectomy, radioactive iodine therapy, or chronic administration of drugs such as Sulfonamides and phenobarbital that interfere with thyroid hormone synthesis (Kooistra, 2005) [12] .

Risk Factors

 Breed predisposition: Golden Retrievers, Doberman Pinschers, Beagles, and Irish Setters are commonly affected (Graham, 2007) [7] .  Age: Middle-aged dogs (4-10 years) are at higher risk.  Sex: Both sexes are equally susceptible, though neutered dogs may show slightly increased risk (Ferguson, 1994) [6] .  Genetic factors: Certain MHC haplotypes have been linked to autoimmune thyroiditis in Beagles and Dobermans (Kennedy et al., 2006) [10] .

Pathogenesis of Hypothyroidism 2.3.1 Destruction of Thyroid Follicles

In lymphocytic thyroiditis, autoreactive lymphocytes target thyroid antigens (e.g., thyroglobulin), leading to follicular damage and decreased hormone output.

Hormonal Deficiency

Reduced T 4 and T 3 lead to decreased metabolic activity in virtually all tissues  Carbohydrate metabolism: Reduced gluconeogenesis and glycogenolysis.  Lipid metabolism: Hypercholesterolemia due to impaired lipid clearance.  Protein metabolism: Altered turnover leading to muscle weakness.  Thermoregulation: Reduced basal metabolic rate and cold intolerance.

Pituitary-Thyroid Feedback Mechanism

Decreased thyroid hormone levels normally stimulate increased TSH secretion. In primary hypothyroidism, serum TSH is elevated but ineffective due to glandular failure (Mooney, 2011) [16] .

Natural Progression

Hypothyroidism usually progresses slowly. Subclinical thyroiditis may persist for years before hormone levels fall enough to cause overt clinical signs. Dogs may remain euthyroid with positive thyroid autoantibodies long before showing clinical illness (Egbert et al., 2024) [4] .

Clinical Signs and Diagnosis

Hypothyroidism in dogs is often described as a "great imitator" because the clinical presentation overlaps with many other systemic and dermatological disorders. The onset is usually insidious and progressive, and the clinical picture varies depending on the severity and duration of the disease.

Diagnosis is challenging and requires a combination of clinical suspicion, laboratory evaluation, and confirmatory thyroid function testing.

General Clinical Manifestations 3.1.1 Metabolic and Constitutional Signs

 Lethargy and Mental Dullness: Reduced metabolic activity leads to decreased energy levels, inactivity, and somnolence. Owners often describe affected dogs as "sluggish" or "lazy" (Mooney, 2011) [6] .  Weight Gain without Polyphagia: Hypothyroid dogs often gain weight despite normal or decreased food intake, due to reduced basal metabolic rate (Ferguson, 1994) [6] .

 Exercise Intolerance and Weakness: Due to impaired energy metabolism and muscle function.  Cold Intolerance: Dogs prefer warm environments, seek heat sources, and may shiver easily.

Gastrointestinal and Cardiovascular Signs

 Constipation and occasional diarrhea due to altered motility.  Bradycardia and low-voltage QRS complexes on ECG due to reduced cardiac output (Dixon, 2005) [3] .  Dilated cardiomyopathy-like changes have been rarely reported but usually resolve after levothyroxine therapy.

Neurological Signs

 Peripheral neuropathies: knuckling, ataxia, proprioceptive deficits.  Cranial nerve dysfunction: facial nerve paralysis, vestibular dysfunction.  Rarely, central nervous signs due to secondary hypothyroidism or pituitary mass lesions (Scott-Moncrieff, 2015) [21] .

Dermatological Manifestations

Dermatological changes are among the most common and characteristic features of canine hypothyroidism.  Alopecia: Non-pruritic, bilateral, and symmetrical hair loss, initially affecting the trunk, tail ("rat tail"), and neck. Hair often fails to regrow after clipping (Graham, 2007) [7] .  Seborrhea: Either dry (seborrhea sicca) or oily (seborrhea oleosa).  Hyperpigmentation: Secondary to chronic alopecia and lichenification.  Pyoderma and Otitis Externa: Recurrent infections due to impaired skin barrier and immunosuppression.  Myxoedema: Accumulation of glycosaminoglycans in the dermis leading to thickened skin, especially around the face, giving a "tragic expression."

Reproductive Manifestations

 Females: Prolonged interestrous intervals, silent heats, infertility, abortion, or stillbirths (Cecere, 2023) [1] .  Males: Reduced libido, testicular atrophy, and poor semen quality.  Both sexes may show delayed puberty in congenital hypothyroidism.

Ocular Manifestations

 Corneal lipid dystrophy, dry eye (keratoconjunctivitis sicca), and blepharitis are occasionally seen in hypothyroid dogs (Dixon, 2005) [3] .

Diagnostic Approach 3.5.1 Clinical Suspicion

A diagnosis should be suspected in middle-aged, predisposed breeds presenting with classic metabolic and dermatological signs. [20] . [8] .  Drug Interference: Glucocorticoids, phenobarbital, and Sulfonamides can suppress thyroid hormone synthesis or secretion.  Breed Variations: Sight hounds (Greyhounds, Borzoi) naturally have lower TT 4 concentrations, which can mimic hypothyroidism.

Routine Laboratory Findings

Thyroid Function

Differential Diagnosis

The clinical presentation of canine hypothyroidism overlaps with many systemic, dermatological, metabolic, and endocrine disorders. Because of this, misdiagnosis is common if diagnostic investigations are based solely on clinical signs or total T 4 concentrations. A systematic approach to differential diagnosis is essential to distinguish hypothyroidism from other conditions that cause similar signs.

Dermatological Differentials 4.1.1 Hyperadrenocorticism (Cushing's disease)

 Both hypothyroidism and Cushing's cause bilaterally symmetrical alopecia, thin hair coat, hyperpigmentation, and recurrent skin infections.  However, Cushing's is more often associated with abdominal distension ("pot-bellied appearance"), polyuria, polydipsia, and calcinosis cutis (Feldman & Nelson, 2004) [5] .

Alopecia X (Adrenal Hyperplasia-like Syndrome)

 Seen in Nordic breeds; presents as truncal alopecia and hyperpigmentation.  Unlike hypothyroidism, affected dogs are usually bright, active, and metabolically normal (Llyod & Cerundolo, 2001) [15] .

Seasonal Flank Alopecia

 Characterized by non-inflammatory alopecia restricted to the flanks, occurring seasonally and self-resolving.  Distinguished by absence of systemic signs (Scott-Moncrieff, 2015) [21] .

Demodicosis and Dermatophytosis

 Both can cause alopecia, scaling, and secondary pyoderma.  Deep skin scrapings, fungal cultures, or PCR confirm the diagnosis (Moriello, 2014) [17] .

Metabolic and Systemic Differentials 4.2.1 Obesity and Reduced Activity (Non-endocrine)

 Obesity due to overfeeding or sedentary lifestyle may mimic hypothyroid-associated weight gain.  In such cases, dermatological changes and metabolic abnormalities (e.g., hypercholesterolemia) are absent.

Chronic Renal Disease and Hepatic Disease

 These conditions may contribute to lethargy, weakness, and weight gain.  They are also associated with euthyroid sick syndrome, where thyroid hormone levels are suppressed secondarily to systemic illness (Graham et al., 2002) [8] .

Endocrine Differentials 4.3.1 Hypoadrenocorticism (Addison's disease)

 May share signs such as lethargy, weakness, and gastrointestinal disturbances.  However, Addison's is usually characterized by electrolyte abnormalities (hyponatremia, hyperkalemia) and waxing-waning GI crises (Kintzer & Peterson, 1997) [11] .

Diabetes Mellitus

 Dogs may present with lethargy and weight changes.  Unlike hypothyroidism, diabetes is associated with polyuria, polydipsia, polyphagia, and hyperglycemia (Nelson & Reusch, 2014) [18] .

Hypopituitarism

 Rare, but may cause secondary hypothyroidism due to low TSH production.  Often associated with other pituitary hormone deficiencies.

Neuromuscular Differentials

Hypothyroidism may mimic neuromuscular disorders because of its association with polyneuropathy and myopathy.  Degenerative Myelopathy and Chronic Intervertebral Disc Disease present with weakness and ataxia but without metabolic or dermatologic abnormalities.

 Myasthenia Gravis causes generalized weakness and exercise intolerance but is distinguished by the presence of acetylcholine receptor autoantibodies (Dewey & da Costa, 2016) [2] .

Laboratory and Diagnostic Differentials  Euthyroid Sick Syndrome (ESS):

A major confounder where systemic illness suppresses thyroid hormones without true hypothyroidism (Dixon, 2005) [3] .  Drug-induced Hypothyroxinaemia: Glucocorticoids, Sulfonamides, phenobarbital, and NSAIDs may artificially lower TT 4 concentrations.  Breed-related Variations: Greyhounds, Borzois, and other sighthounds normally have lower TT 4 levels (Graham, 2007) [7] .

Diagnostic

Pathophysiology of Canine Hypothyroidism

The pathophysiology of canine hypothyroidism involves a complex interplay between thyroid gland destruction, impaired hormone synthesis, and disruption of hypothalamicpituitary-thyroid (HPT) axis regulation. Most cases are due to primary thyroid gland dysfunction, while fewer arise from secondary pituitary disease or rare tertiary hypothalamic defects. The result is inadequate secretion of thyroxine (T 4 ) and triiodothyronine (T 3 ), leading to multisystemic metabolic derangements.

Thyroid Hormone Production and Regulation

 The thyroid gland synthesizes T 4 (thyroxine) and T 3 (triiodothyronine) under the control of thyroidstimulating hormone (TSH) released by the anterior pituitary (Ferguson, 1994) [6] .  The hypothalamus secretes thyrotropin-releasing hormone (TRH), stimulating TSH secretion.  T 4 is the major circulating hormone, while T 3 (the active form) is mostly generated by peripheral deiodination of T 4 (Dixon, 2005) [3] .  Thyroid hormones act on virtually all tissues to regulate metabolism, protein synthesis, lipid turnover, thermogenesis, and growth.

 An immune-mediated process where autoreactive lymphocytes infiltrate and progressively destroy thyroid follicles.

 Associated with thyroglobulin autoantibodies (TgAA), which serve as biomarkers of this disease (Graham et al., 2002) [8] .  Early stages show compensatory hypertrophy and elevated TSH, while later stages result in complete gland atrophy and hypothyroidism.

Idiopathic Thyroid Atrophy

 Characterized by replacement of thyroid parenchyma with adipose and connective tissue (Mooney, 2011) [16] .  The exact cause is unclear but may represent an end-stage of autoimmune thyroiditis.

Secondary Hypothyroidism

 Results from pituitary TSH deficiency, often due to pituitary tumors, congenital hypopituitarism, or acquired pituitary dysfunction.  Leads to thyroid gland inactivity despite structurally normal thyroid tissue (Peterson et al., 1997) [20] .

Tertiary Hypothyroidism (Rare)

 Caused by inadequate TRH secretion from the hypothalamus.  Extremely uncommon in dogs, usually reported in experimental models (Dixon, 2005) [3] .

Peripheral Hormone Metabolism and Resistance

 In some conditions, thyroid hormone synthesis may be normal, but peripheral metabolism of T 4 to T 3 is impaired, or tissue responsiveness is reduced.  Euthyroid Sick Syndrome is an example, where systemic illness suppresses thyroid hormone activity at the tissue level without true hypothyroidism (Graham, 2007) [7] .

Molecular and Genetic Basis

 Certain breeds (Dobermans, Golden Retrievers, Beagles) are predisposed to autoimmune thyroiditis, suggesting a genetic basis for immune dysregulation (Kennedy et al., 2006) [10] .  Specific MHC class II alleles have been implicated in susceptibility.

Systemic Effects of Hypothyroidism 5.7.1 Metabolic

 Reduced basal metabolic rate leads to lethargy, obesity, cold intolerance, and exercise intolerance (Ferguson, 1994) [6] .

Dermatological

 Decreased epidermal turnover and altered keratinization cause alopecia, seborrhea, and hyperpigmentation (Graham, 2007) [7] .

Neuromuscular

 Hypothyroid myopathy and neuropathy result from altered neuromuscular transmission and accumulation of mucopolysaccharides in peripheral nerves (Scott-Moncrieff, 2015) [21] .

Cardiovascular

 Thyroid hormones normally increase myocardial contractility and heart rate. Their deficiency leads to bradycardia, reduced stroke volume, and occasionally arrhythmias (Dixon, 2005) [3] .

Reproductive

 Hypothyroidism alters gonadotropin secretion and steroid hormone metabolism, resulting in infertility, irregular cycles, and poor semen quality (Cecere, 2023) [1] .

Summary of

Routine Hematology and Biochemistry

Although not diagnostic on their own, these tests provide supportive evidence and help rule out concurrent illness.

Hematological Findings

 Mild non-regenerative anemia (normocytic, normochromic) is observed in 30-40% of hypothyroid dogs (Dixon, 2005) [3] .  Leukogram is usually normal, but recurrent infections may lead to neutrophilia.

Serum Biochemistry

 Hypercholesterolemia: Found in ~75% of hypothyroid dogs due to decreased LDL receptor activity and reduced lipid metabolism (Peterson et al., 1997) [20] .  Hypertriglyceridemia: Common but less consistent than hypercholesterolemia.  Mild to moderate increases in liver enzymes (ALT, ALP) due to fatty liver infiltration.  Creatine kinase (CK) elevation in cases with hypothyroid myopathy. [8] .  High sensitivity but low specificity.

Basal

Free T4 (fT4)

 Represents the biologically active fraction of T 4 .

 Measured by equilibrium dialysis (ED) → gold standard method for specificity.  Less affected by systemic illness and drugs than TT 4 (Mooney, 2011) [16] .

Total T3 (TT3) and Free T3 (fT3)

 Of limited diagnostic value in dogs, as serum T 3 concentrations fluctuate and may remain normal in hypothyroidism.

Endogenous Thyroid-Stimulating Hormone (TSH)

 In primary hypothyroidism: elevated TSH due to loss of negative feedback (Graham, 2007) [7] .  However, ~25% of hypothyroid dogs have normal TSH levels → limiting sensitivity (Peterson et al., 1997) [20] .  Best used in combination with TT 4 and fT 4 . [10] .  Can be detected using ELISA-based assays.  TgAA-positive dogs may be euthyroid initially but are at increased risk of progression to hypothyroidism.

Dynamic and

Anti-T3 and Anti-T4 Antibodies

 May cause assay interference, leading to false elevation of TT 3 or TT 4 .

Imaging Modalities 6.6.1 Thyroid Ultrasonography

 Hypothyroid thyroid glands appear small, hypoechoic, and heterogeneous (Dixon, 2005) [3] .  Useful for differentiating thyroiditis from neoplasia.

Scintigraphy

 Involves administration of radionuclides (e.g., technetium-99m pertechnetate).  Provides information on thyroid size, function, and uptake patterns.  Limited by cost and availability but highly sensitive.

Molecular and Genetic Markers

 Ongoing research into DLA (dog leukocyte antigen) class II gene associations with autoimmune thyroiditis (Kennedy et al., 2006) [10] .

 May help in identifying predisposed breeds and in early screening.

Stepwise

Treatment and Management of Canine Hypothyroidism

The cornerstone of hypothyroidism therapy in dogs is lifelong thyroid hormone replacement, primarily with synthetic levothyroxine (L-thyroxine). Proper management requires careful dosing, monitoring, and adjustment tailored to individual patient response. In some cases, management of concurrent diseases and supportive therapy are also critical.

General Principles of Therapy

 Hypothyroidism is a lifelong condition, requiring continuous medication.  Early diagnosis and treatment prevent secondary complications such as infertility, neuropathies, and chronic dermatopathies (Dixon, 2005) [3] .  Treatment is aimed at restoring normal serum thyroid hormone concentrations and alleviating clinical signs (Mooney, 2011) [16] .

Levothyroxine (L-Thyroxine) Therapy 7.2.1 Drug of Choice

 Synthetic L-thyroxine (T 4 ) is the treatment of choice.  T 4 is preferred over T 3 because it has a longer half-life, more stable absorption, and allows peripheral conversion to T 3 depending on tissue demand (Peterson et al., 1997) [20] .

Dosage

 Initial recommended dose: 0.02 mg/kg orally every 12 hours.  Alternatively, 0.02-0.04 mg/kg once daily (total dose not exceeding 0.8 mg per dog).  Twice-daily dosing is often recommended initially due to variable bioavailability, but many dogs can be stabilized on once-daily therapy (Dixon, 2005) [3] .

Formulation and Administration

 Available as tablets (0.1-0.8 mg).  Should ideally be administered consistently with or without food, as dietary factors can affect absorption.

Bioavailability

 Varies between 10-50% in dogs.  Gastrointestinal disease, concurrent medications (e.g., sucralfate, calcium, iron supplements), and diet may reduce absorption (Graham, 2007) [7] .

Monitoring Therapy 7.3.1 Clinical Response

 Earliest improvement: Increased activity and alertness within 1-2 weeks.

 Dermatological improvement: Hair regrowth and skin normalization within 2-3 months.  Weight normalization: Gradual over 3-6 months.

Laboratory Monitoring

 Recheck serum TT 4 4-6 weeks after starting therapy.  Sampling should be done  Peak level: 4-6 hours post-pill.  Trough level: Just before next dose.  Goal: TT 4 in the upper half of reference range at trough and slightly above reference range at peak (Peterson et al., 1997) [20] .  Adjust dose based on TT 4 levels and clinical signs.

Management of Refractory Cases

If dogs fail to respond despite adequate dosing, consider 1. Owner compliance issues (missed doses, incorrect administration). 2. Poor absorption (drug-diet interactions, gastrointestinal disease). 3. Concurrent illness (Euthyroid Sick Syndrome masking response). 4. Rare thyroxine resistance (Mooney, 2011) [16] .

Adverse Effects of Therapy Overdose (Iatrogenic Hyperthyroidism)

 Signs: Polyuria, polydipsia, polyphagia, weight loss, hyperactivity, panting, tachycardia.  Confirmed by elevated TT 4 .  Management: Discontinue therapy for several days, restart at reduced dose.  Long-term toxicity is rare if monitoring is adequate.

Special Considerations 7.6.1 Secondary Hypothyroidism

 Requires L-thyroxine supplementation, but pituitary disease (e.g., tumors) may necessitate additional therapy.

Dogs with Cardiac Disease

 Start with lower initial doses to avoid precipitating tachyarrhythmias or worsening heart failure.

Breeding Dogs

 Reproductive dysfunction improves with treatment. However, monitoring is crucial to restore fertility and avoid iatrogenic complications (Cecere, 2023) [1] .

Adjunctive and Supportive Therapy

 Management of concurrent infections: Skin and ear infections should be treated with antimicrobials alongside thyroid supplementation.  Nutritional support: Weight management and balanced diets aid in recovery.  Neurological rehabilitation: Physiotherapy may be useful in cases with hypothyroid neuropathy.

Prognosis

 Prognosis is excellent with proper treatment.  Most clinical signs resolve within 4-12 weeks, though dermatological changes may take longer.

 Dogs require lifelong therapy and periodic monitoring to maintain euthyroid status.

Complications and Associated Conditions in Canine Hypothyroidism

Hypothyroidism in dogs, if left untreated or inadequately managed, can result in a wide range of systemic complications. Since thyroid hormones are essential regulators of metabolism, growth, and organ function, their deficiency impacts nearly every physiological system. Furthermore, hypothyroidism may predispose dogs to other comorbidities, complicating the clinical picture and management.

Dermatological Complications 8.1.1 Chronic Pyoderma and Otitis

 Dogs with hypothyroidism have reduced skin immunity, predisposing them to recurrent bacterial skin infections and otitis externa (Panciera, 1994) [19] .  Secondary Malassezia dermatitis may also occur due to altered lipid metabolism.

Myxoedema

 Accumulation of mucopolysaccharides in dermis results in characteristic facial puffiness and "tragic expression."  Severe generalized myxoedema can progress to myxoedema coma, a rare but life-threatening complication (Kooistra, 2006) [13] .

Reproductive and Fertility Issues 8.2.1 Female Dogs

 Infertility, silent heats, prolonged inter-estrous intervals, and pseudopregnancy may be observed (Cecere, 2023) [1] .

Male Dogs

 Testicular atrophy, reduced libido, and decreased sperm quality are linked with chronic hypothyroidism.

Neurological Complications 8.3.1 Peripheral Neuropathy

 Hypothyroidism can cause polyneuropathy with signs like weakness, ataxia, hyporeflexia, and cranial nerve deficits (Dixon, 2005) [3] .

Vestibular Dysfunction

 Some hypothyroid dogs exhibit head tilt, facial paralysis, and ataxia due to central or peripheral vestibular involvement (Tagawa et al., 2015) [22] .

Coma (Myxoedema Coma)

 Rare end-stage complication characterized by profound lethargy, hypothermia, bradycardia, and coma.  Requires emergency IV thyroxine and supportive therapy.

Cardiovascular Complications 8.4.1 Bradycardia and Low Cardiac Output

 Reduced myocardial contractility and low voltage ECG are common findings (Lefebvre et al., 2006) [14] .

Atherosclerosis and Hyperlipidaemia

 Hypothyroid dogs exhibit marked hypercholesterolemia and triglyceridemic, predisposing them to atherosclerosis a rare but significant complication compared to humans.

Arrhythmias

 Conduction abnormalities (sinus bradycardia, AV block) may occur.

Ocular Manifestations

 Corneal lipid deposits and keratoconjunctivitis sicca (dry eye) have been documented in hypothyroid dogs (Kooistra, 2006) [13] .  Rarely, retinal changes may be observed due to altered metabolism.

Musculoskeletal and

Hematological Complications

 Non-regenerative, normocytic, normochromic anemia is a frequent finding (Panciera, 1994) [19] .  Occasionally, mild coagulopathy due to altered platelet function may be observed. [19] .

Metabolic and Endocrine Associations

Hematological and Biochemical Findings 9.2.1 Hematology

 Non-regenerative, normocytic, normochromic anemia is present in up to 30-40% of cases (Dixon, 2005) [3] .

Biochemistry

 Hypercholesterolemia (>7.8 mmol/L) and hypertriglyceridemia are hallmark findings (Mooney, 2011) [16] .  Mild increases in liver enzymes (ALT, ALP) are sometimes observed. [3] .

Basal Thyroid

Thyroid-Stimulating Hormone (TSH) Testing

 Endogenous canine TSH is elevated in ~75% of hypothyroid dogs.  When combined with TT 4 or fT 4 , the diagnostic accuracy increases significantly (Peterson et al., 1997) [20] .  A dog with low TT 4 and high TSH is strongly suggestive of primary hypothyroidism. [22] .  Scintigraphy (Radionuclide Imaging): Helps assess thyroid uptake and differentiate hypothyroidism from euthyroid sick syndrome, but limited by cost and availability.

Dynamic

Differential Diagnosis

Because many conditions mimic hypothyroidism, careful exclusion is essential values, leading to misdiagnosis if breed differences are ignored (Mooney, 2011) [16] . [3] .  Clinical signs such as lethargy, weight gain, and alopecia usually resolve within weeks to months.  Dermatological recovery (hair regrowth, resolution of seborrhea) may take 2-6 months.

Prognostic Factors

 Dogs diagnosed early have a better recovery with fewer irreversible complications.  Chronic untreated hypothyroidism may leave residual neuropathy, infertility, or dermatological scarring (Kooistra, 2006) [13] .  Severe complications such as myxoedema coma carry a guarded prognosis despite treatment. [16] .

Owner Education

 Owners must be educated on drug administration, recognizing relapse or overdose, and importance of routine monitoring.

Future Perspectives 10.4.1 Advances in Diagnostic Techniques

 Development of more specific biomarkers (thyroglobulin autoantibodies, molecular markers) to distinguish hypothyroidism from euthyroid sick syndrome (Graham, 2007) [7] .  High-resolution ultrasonography and PET-CT imaging offer promise for early thyroid pathology detection. [10] .

Nutritional Research

 Nutraceuticals, omega-3 fatty acids, and antioxidants are being studied for their role in modulating autoimmune thyroiditis and improving metabolic recovery.

Summary of Prognosis and Future Outlook

 With proper therapy, hypothyroid dogs live normal, healthy lives.  Early detection and genetic control programs hold promise in reducing disease incidence.  Emerging diagnostic methods and therapies may revolutionize the way hypothyroidism is diagnosed and managed in the coming decades.

References

1. Cecere J. Hypothyroidism and its impact on canine reproduction. Clinical Theriogenology. 2023;15(2):99104.
2. Dewey CW, da Costa RC. Neurologic differentials for hypothyroidism in dogs. Practical Veterinary Neurology. 2016;2(3):201-214.
3. Dixon RM. Neurological manifestations of hypothyroidism in dogs. Veterinary Record. 2005;157(19):573-580.
4. Egbert RJ, Basu P, Refsal KR, Petroff MG, Petroff BK. Changes in thyroid hormone concentrations over time in dogs with autoimmune thyroiditis. American Journal of Veterinary Research. 2024;85(6):1102-1126.
5. Feldman EC, Nelson RW. Canine and feline endocrinology and reproduction. 3rd ed. Philadelphia: W.B. Saunders; 2004. p. 86-120.
6. Ferguson DC. Testing for hypothyroidism in dogs. Veterinary Clinics of North America: Small Animal Practice. 1994;24(3):515-539.
7. Graham PA. Etiopathology findings of canine hypothyroidism. Journal of Small Animal Practice. 2007;48(4):195-200.
8. Graham PA, Nachreiner RF, Refsal KR. Etiopathologic findings of canine hypothyroidism. Veterinary Clinics of North America: Small Animal Practice. 2002;32(4):915933.
9. Kemppainen RJ. Etiopathogenesis of canine hypothyroidism. Journal of Small Animal Practice. 1994;35(7):365-370.
10. Kennedy LJ, Quarmby S, Happ GM, Barnes A. Association of canine hypothyroidism with a common major histocompatibility complex DLA class II allele. Tissue Antigens. 2006;68(1):82-86.
11. Kintzer PP, Peterson ME. Diagnosis and management of canine hypoadrenocorticism. Veterinary Clinics of North America: Small Animal Practice. 1997;27(2):349-357.
12. Kooistra HS. Drugs affecting thyroid function in dogs. Journal of Veterinary Pharmacology and Therapeutics. 2005;28(1):55-65.
13. Kooistra HS. Clinical complications of canine hypothyroidism. Journal of Small Animal Practice. 2006;47(10):591-600.
14. Lefebvre HP, Laroute V, Concordet D. Cardiovascular changes in dogs with hypothyroidism. Journal of Veterinary Cardiology. 2006;8(1):55-62.
15. Lloyd DH, Cerundolo R. Alopecia X in dogs. Veterinary Record. 2001;148(2):60-60.
16. Mooney CT. Canine hypothyroidism: a review of aetiology and diagnosis. New Zealand Veterinary Journal. 2011;59(3):105-114.
17. Moriello KA. Fungal skin diseases of dogs. Veterinary Clinics of North America: Small Animal Practice. 2014;44(1):111-132.
18. Nelson RW, Reusch CE. Animal models of diabetes mellitus. Trends in Endocrinology and Metabolism. 2014;25(7):375-384.
19. Panciera DL. Hypothyroidism in dogs: 66 cases (19871992). Journal of the American Veterinary Medical Association. 1994;204(5):761-767.
20. Peterson ME, Melian C, Nichols R. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs. Journal of the American Veterinary Medical Association. 1997;211(11):13961402.
21. Scott-Moncrieff JC. Clinical signs and concurrent diseases of hypothyroidism in dogs. Veterinary Focus. 2015;25(1):16-23.
22. Tagawa M, Kanakubo K, Miyahara K. Ultrasonographic evaluation of thyroid glands in dogs with hypothyroidism. Journal of Veterinary Internal Medicine. 2015;29(2):524-529.